Multiorgan Involvement in COVID-19 and Possible Therapies

In late 2019, China reported cases of respiratory illness in humans, which involved a novel Coronavirus SARS-CoV-2 (also known as 2019-nCoV). The World Health Organization (WHO) termed the disease COVID-19 (i.e., Coronavirus disease 2019). Most of the morbidity and mortality from COVID-19 is largely...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathe, Prachee, Singh, Vijay Sundar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd. 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416215/
http://dx.doi.org/10.1055/s-0040-1714151
_version_ 1783569282087518208
author Sathe, Prachee
Singh, Vijay Sundar
author_facet Sathe, Prachee
Singh, Vijay Sundar
author_sort Sathe, Prachee
collection PubMed
description In late 2019, China reported cases of respiratory illness in humans, which involved a novel Coronavirus SARS-CoV-2 (also known as 2019-nCoV). The World Health Organization (WHO) termed the disease COVID-19 (i.e., Coronavirus disease 2019). Most of the morbidity and mortality from COVID-19 is largely due to acute viral pneumonitis that leads to acute respiratory distress syndrome (ARDS). This article will discuss the clinical features of the multiorgan involvement in COVID-19 as well as the management of patients who become critically ill due to COVID-19.
format Online
Article
Text
id pubmed-7416215
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Thieme Medical and Scientific Publishers Private Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74162152020-08-10 Multiorgan Involvement in COVID-19 and Possible Therapies Sathe, Prachee Singh, Vijay Sundar Journal of Cardiac Critical Care TSS In late 2019, China reported cases of respiratory illness in humans, which involved a novel Coronavirus SARS-CoV-2 (also known as 2019-nCoV). The World Health Organization (WHO) termed the disease COVID-19 (i.e., Coronavirus disease 2019). Most of the morbidity and mortality from COVID-19 is largely due to acute viral pneumonitis that leads to acute respiratory distress syndrome (ARDS). This article will discuss the clinical features of the multiorgan involvement in COVID-19 as well as the management of patients who become critically ill due to COVID-19. Thieme Medical and Scientific Publishers Private Ltd. 2020-08 2020-07-13 /pmc/articles/PMC7416215/ http://dx.doi.org/10.1055/s-0040-1714151 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Sathe, Prachee
Singh, Vijay Sundar
Multiorgan Involvement in COVID-19 and Possible Therapies
title Multiorgan Involvement in COVID-19 and Possible Therapies
title_full Multiorgan Involvement in COVID-19 and Possible Therapies
title_fullStr Multiorgan Involvement in COVID-19 and Possible Therapies
title_full_unstemmed Multiorgan Involvement in COVID-19 and Possible Therapies
title_short Multiorgan Involvement in COVID-19 and Possible Therapies
title_sort multiorgan involvement in covid-19 and possible therapies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416215/
http://dx.doi.org/10.1055/s-0040-1714151
work_keys_str_mv AT satheprachee multiorganinvolvementincovid19andpossibletherapies
AT singhvijaysundar multiorganinvolvementincovid19andpossibletherapies

Ejemplares similares